Fuan Pharmaceutical (Group) Balance Sheet Health
Financial Health criteria checks 5/6
Fuan Pharmaceutical (Group) has a total shareholder equity of CN¥4.3B and total debt of CN¥763.4M, which brings its debt-to-equity ratio to 17.8%. Its total assets and total liabilities are CN¥6.0B and CN¥1.7B respectively. Fuan Pharmaceutical (Group)'s EBIT is CN¥215.5M making its interest coverage ratio -2.4. It has cash and short-term investments of CN¥989.2M.
Key information
17.8%
Debt to equity ratio
CN¥763.35m
Debt
Interest coverage ratio | -2.4x |
Cash | CN¥989.25m |
Equity | CN¥4.28b |
Total liabilities | CN¥1.74b |
Total assets | CN¥6.02b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300194's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 300194's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥524.0M).
Debt to Equity History and Analysis
Debt Level: 300194 has more cash than its total debt.
Reducing Debt: 300194's debt to equity ratio has increased from 1% to 17.8% over the past 5 years.
Debt Coverage: 300194's debt is well covered by operating cash flow (72.2%).
Interest Coverage: 300194 earns more interest than it pays, so coverage of interest payments is not a concern.